HindustanTimes Thu,27 Nov 2014

Patents on Allergan eye drugs revoked

AFP  New Delhi, August 09, 2013
First Published: 22:33 IST(9/8/2013) | Last Updated: 22:35 IST(9/8/2013)

The government has revoked patents granted to US company Allergan for two glaucoma drugs, the latest in a series of setbacks for Western firms in India's fast-expanding pharmaceutical market.


The patent appeal board revoked two of the company's patents on medicines for treatment of glaucoma, an illness that damages the optic nerve.

According to a notice posted on the website of the Intellectual Property Appellate Board, the  drugs Ganfort and Combigan do not stand the "test of innovation" and are ineligible for patents.

Last week, it revoked patents related to GlaxoSmithKline's breast cancer drug Tykerb that would have delayed the launch of generic versions of the medicine for two-and-half years to 2021.

more from Business

Nippon to up Reliance MF stake to 49%; Rs 657 cr for first 9%

Japanese financial services giant Nippon will hike its stake in India's top fund house Reliance Mutual Fund from 26% to 49%, while investing Rs 657 crore for the first tranche of 9%.

Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved